Psyence Biomedical Signs Exclusive Licensing Agreement with Optimi Health
Psyence Biomedical ( (PBM) ) has provided an announcement.
GEN9 天
Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu ...
The company is launching a Phase Ib study that will test its first gene therapy in patients with locally advanced rectal ...